Share this Post!

In its commitment to provide effective and efficient releasing of authorizations to its clients, the Food and Drug Administration will re-open its Releasing Unit at the FDA main office located at Civic Drive Alabang Muntinlupa City.

Due to the existing COVID-19 protocols, releasing of authorization will be scheduled via the following email address:

[email protected]

[email protected]

Only clients with the given schedule will be accommodated by the releasing personnel. Walk-in clients will not be accommodated.

All other provisions of FDA Advisory No. 2022-0001 not affected by this amendment shall remain valid and effective.

Attachments